Medical Compression Garments Market Size, Share, Growth, and Industry Analysis, By Type (Upper Compression Garments,Lower Compression Garments), By Application (Varicose Vein,Wound Care,Burns,Oncology,Other Indications), Regional Insights and Forecast to 2035

Medical Compression Garments Market Overview

The global Medical Compression Garments Market size is projected to grow from USD 3317.47 million in 2026 to USD 3623.68 million in 2027, reaching USD 7341.83 million by 2035, expanding at a CAGR of 9.23% during the forecast period.

The Medical Compression Garments Market in 2024 is estimated at about USD 2,731 million globally; by 2031 the market is forecast to reach around USD 4,038 million, under current growth conditions. In 2023, Medical Compression Garments Market Share by region had North America contributing about 30% of global volume, Europe about 35%, Asia-Pacific around 22%, Latin America about 5%, and Middle East & Africa approximately 4%. In type segmentation, Compression Socks plus Body Garments together hold over 50% of units sold and market usage. Within applications, Hospitals & Clinics account for over 60% of demand for medical compression garments.

In the USA market, in 2024 static‐compression therapy forms about 66.07% of technology share in compression garments and related products; dynamic compression accounts for remaining 33.93% in that landscape. Within the U.S., approximately 58 million adults are aged 65+, accounting for about 17.3% of population, a demographic heavily contributing to demand for Medical Compression Garments Market Growth. U.S. performs 790,000 knee replacements and 544,000 hip replacements annually, adding to demand for post‐surgical compression garment usage. In 2023, U.S. compression therapy market was estimated at about USD 1,525.7 million in static + dynamic compression products and medical compression garments combined.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Over 65% of demand growth is driven by rising incidence of venous disorders and post‐surgical recovery needs; approximately 40% increase in awareness among healthcare professionals and patients in non‐invasive treatment methods.
• Major Market Restraint: Around 30% of users report discomfort and low compliance due to poor garment fit or heat retention; approximately 25% of intended users abandon use within first two weeks because of comfort issues.
• Emerging Trends: About 40% of manufacturers are innovating with moisture‐wicking and breathable fabric technology; roughly 20% rise in adoption of custom‐fit and digitally measured garment sizing.
• Regional Leadership: North America holds approximately 38% share of Medical Compression Garments Market by value in 2025; Europe around 30%, Asia‐Pacific about 24%, Latin America and MEA smaller segments.
• Competitive Landscape: Top 7 players control nearly 50% of the global market; Essity and SIGVARIS together account for about 33% of global sales value among manufacturers in 2024.
• Market Segmentation: Upper compression garments approx 35% of product share; lower garments 50%; other types 15%; in types, compression socks 35%, body garments 25%, shorts & leggings 20%, post‐surgical girdles 15%, face & neck garments 5%.
• Recent Development: Over 28% of companies introduced new product lines with adaptive compression or digitally measured fitting in the last year; over 30% of garments in U.S. markets now include antimicrobial or odor control fabrics.

Medical Compression Garments Market Latest Trends

In recent years, Medical Compression Garments Market Trends show that the static compression therapy segment accounted for about 67.2% share in 2024 of the compression therapy market, reflecting dominance of garments, stockings, wraps over dynamic pumps. There is evidence that 52.45% of product mix in 2024 for compression therapy is from garments versus other modalities. Demand for post‐surgical girdles has seen growth: global Post‑Surgical compression garment demand increased by over 22.3% between 2020 and 2023 in cosmetic & reconstructive surgery use. In application usage, lymphedema treatment captured about 36.9% of product application share in compression therapy in 2024. Venous leg ulcers accounted for about 34.33% of application usage in that same period. Hospitals and clinics continue to dominate as end‑users with about 45.2% share of market volume in 2024. Among distribution channels, offline retail (pharmacies, medical supply stores) held 55.6% share in 2023; hospitals & clinics 27.8%; online retail has carved out about 16.6% but increasing rapidly. Material innovation trends: moisture‐wicking fabrics improved comfort by over 30% per patient feedback; custom sizing improved compliance in clinical trials by approx 18% compared to generic sizing. These Medical Compression Garments Market Insights reflect shifts in product type, application, technology, and end‐user behaviors.

Medical Compression Garments Market Dynamics

DRIVER

"Rising prevalence of chronic venous disorders and post""‑surgical recovery needs"

Patients with chronic venous insufficiency (CVI), deep vein thrombosis (DVT) and lymphedema number in the tens of millions globally; in U.S., adult population above age 65 (58 million) is especially impacted. Surgical procedures such as knee and hip replacements total about 1.334 million annually (knee 790,000; hip 544,000) driving post‑surgical compression garment prescriptions. Awareness and adoption of non‐invasive treatments have increased by about 40% among healthcare professionals and patients. Static compression therapy accounted for about 66.07% of technology share in U.S. in 2024, reflecting high demand. Materials improvements (breathable, antimicrobial) have improved comfort by over 30%, reducing abandonment. Product segmentation indicates garments hold 52.45% of therapy product usage globally in 2024, reinforcing garment demand as key driver.

RESTRAINT

"Discomfort, compliance issues, and cost reimbursement limits"

Roughly 30% of users report discomfort due to heat retention or poor fit; clinical compliance drops by that amount within first two weeks for many users. Insurance reimbursement in some regions covers fewer than 25–30% of indications for compression garments, limiting purchases. In developing regions, up to 40% of patients cite pricing as barrier despite awareness. Production costs for advanced fabrics increased by over 20% in last two years, contributing to higher end prices. Lack of standardization in sizing leads to misfitting: about 35% of returns in online sales are due to wrong size or fit. Regulatory requirements and approvals, varying per country, add delay: e.g. more than 20 distinct regulatory certifications needed across major markets.

OPPORTUNITY

"Growth in personalized and technology""‑enhanced compression garments"

Custom‑fit garments now being used by about 20% of prescription and consumer‑grade cases; digital measurement / 3D scanning technologies introduced by more than 28% of market players. Adaptive compression zones in garments present in over 25% of new product offerings. Smart textiles with sensors for pressure feedback launched in several trials, tracking pressure in real time, e.g. devices delivering pressures exceeding 22 kPa for certain wearable robotic dynamic compression use cases. Expansion of e‑commerce: in some markets over 45% of purchases occurring via online retail, opening channels into previously under‑penetrated regions. Home care settings contribute about 40% of global demand, giving opportunity to penetrate patient self‑care.

CHALLENGE

"Regulatory complexity, standardization, and user awareness"

Standards for pressure (mmHg levels), fabric porosity, antimicrobial treatment vary; multiple pressure levels defined: light (8‑15 mmHg), moderate (15‑20 mmHg), firm (20‑30 mmHg), extra firm (30‑40 mmHg), medical grade above 40 mmHg. Misunderstanding pressures causes under‑ or over‑use. Health authorities in many countries do not clearly reimburse medical compression garments in post‐surgical, burn, oncology indications; only 23 surgical indications in Germany are covered by statutory insurance. In U.S., only 38% of employer‑sponsored health plans have added compression wear coverage for post‑operative garments since 2021. Manufacturing consistent sizing remains challenge: 35% returns in online channels due to sizing issues. Also, supply chain costs for raw materials (nylon, spandex, cotton blends) have increased by more than 20% year‑over‑year in several major manufacturing hubs, pushing margin pressures.

Medical Compression Garments Market Segmentation

Segmentation in Medical Compression Garments Market by Type includes categories such as Varicose Vein, Wound Care, Burns, Oncology, Other Indications. Segmentation by Application includes Upper Compression Garments and Lower Compression Garments. Each of these segments shows different usage, performance, unit volumes, and growth pressures.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Varicose Vein: This type accounts for a major portion of usage. Varicose Vein treatment constitutes about 40% share within static compression garments applications globally. Compression stockings and wraps for varicose veins are among the most common types, with moderate to firm pressure levels (15‑30 mmHg). Varicose vein segment also dominates return volumes in online sales: over 30% of returns are related to size/fit in this type. The prevalence in adults aged above 50 contributes: in U.S. approx 20‑25 million people are affected by varicose veins, driving consistent demand.

The Varicose Vein segment’s market size in 2025 is estimated at about USD 911 million, representing approximately 30% market share, growing at a CAGR around 9.5% given the rising incidence of venous disorders.

Top 5 Major Dominant Countries in the Varicose Vein Segment:

• United States: Market size approx USD 273 million, share 30% of the Varicose Vein Type globally, CAGR 8.8%.
• Germany: Size USD 120 million, share 13%, CAGR 9.2%.
• Japan: Size USD 95 million, share 10%, CAGR 9.0%.
• India: Size USD 80 million, share 9%, CAGR 10.5%.
• United Kingdom: Size USD 60 million, share 7%, CAGR 8.7%.

Wound Care: Wound Care (venous leg ulcers, diabetic ulcers, surgical wounds) applications hold about 34.33% of global market application by value in 2024. Multi‐layer bandaging and compression wraps dominate this type. In wound care, compression garments and bandages with light to firm pressure (20‑40 mmHg) are standard. The number of patients with venous leg ulcers runs into millions in Europe; in some European countries there are over 1 million patients living with chronic leg ulcers at any time, sustaining demand.

Wound Care is expected to account for about USD 607 million in 2025, roughly 20% share, with CAGR close to 9.0% given increasing surgical volume and diabetic wound care needs.

Top 5 Major Dominant Countries in the Wound Care Segment:

• United States: Size USD 182 million, share 30% of Wound Care globally in this Type; CAGR 8.5%.
• Germany: USD 75 million, 12% share; CAGR 9.1%.
• Japan: USD 60 million, 10%; CAGR 9.0%.
• India: USD 55 million, 9%; CAGR 10.2%.
• France: USD 45 million, 7%; CAGR 8.8%.

Burns: Burn recovery garments (pressure garments for scar management) represent a smaller but significant type. Scar management post burn uses compression garments with defined pressure levels, often extra firm or medical grade (>30 mmHg). Clinical protocols utilize them for 6 to 18 months post injury. Burn type compression garments represent approximately 5‑10% of the type mix in Medical Compression Garments Market, though growth in burn care units in Asia‑Pacific and Latin America raises volume by 15‑20% annually in those regions.

The Burns application segment is projected at about USD 455 million in 2025, 15% share, with CAGR estimated around 9.3%, driven by demand for scar management and reconstructive compression.

Top 5 Major Dominant Countries in the Burns Segment:• United States: USD 136 million, 30% share; CAGR 8.7%.• India: USD 68 million, 15%; CAGR 10.8%.• China: USD 60 million, 13%; CAGR 10.5%.• Germany: USD 45 million, 10%; CAGR 9.0%.• Brazil: USD 36 million, 8%; CAGR 9.5%.

Oncology: Oncology use (post‑mastectomy, lymph node removal leading to lymphedema) accounts for nearly 20% of demand in certain reports. Compression garments for cancer survivors manage swelling and lymphatic fluid; medical grade compression used with moderate to firm levels (20‑30 mmHg, sometimes higher). In lymphedema cases, clinical trials show reduction in swelling by about 30% over standard care when correct compression garments are used. Oncology segment usage rising especially in U.S., Europe, Asia.

The Oncology segment is estimated around USD 607 million in 2025, making up 20% share, with CAGR near 9.4% as lymphedema, post‐radiation swelling, and surgical recuperation demands increase.

Top 5 Major Dominant Countries in the Oncology Segment:

• United States: USD 182 million, share 30%; CAGR 9.0%.
• Japan: USD 80 million, 13% share; CAGR 9.3%.
• Germany: USD 75 million, 12%; CAGR 9.2%.
• UK: USD 55 million, 9%; CAGR 8.9%.
• China: USD 50 million, 8%; CAGR 10.0%.

Other Indications: Other Indications include maternity swelling, travel, lifestyle/compression for general wellness, sports injury prevention. These contribute about 15% of demand globally. In maternity, about 1 in 4 pregnancies see clinical recommendation for mild compression garment. Sports / wellness segments in some markets show adoption rising by 25% annually. These lead to lighter compression types (8‑20 mmHg).

The “Other Indications” segment is forecasted to reach about USD 455 million in 2025, 15% share, with CAGR roughly 9.1%, covering maternity, lymphedema not related to oncology, edema from other causes.

Top 5 Major Dominant Countries in the Other Indications Segment:

• United States: USD 136 million, 30% share; CAGR 8.8%.
• India: USD 55 million, 12%; CAGR 10.3%.
• Germany: USD 50 million, 11%; CAGR 9.1%.
• UK: USD 45 million, 10%; CAGR 8.7%.
• Australia: USD 40 million, 9%; CAGR 9.5%.

BY APPLICATION

Upper Compression Garments: Upper compression garments (arm sleeves, torso vests, face/neck garments) represent about 35% of application share in certain segmentation data. They are used in oncology (post‑mastectomy arm sleeves), burn scar management on torso, neck, or upper body. Upper garment units for face & neck constitute around 5% of global type share; torso/upper body garments about 25% in type mix. In high end medical grade sector, facial garments held 45% share in some medical‑grade compression garment reports, with tops following at 35% and undergarments at 20%. Upper garments’ demand has been pushed by reconstructive surgery and plastic surgery, which increased by 22% between 2020‑2023.

The Upper Compression Garments segment is expected to be worth USD 1,215 million in 2025, about 40% share of the market, growing at a CAGR of approximately 9.0%, driven by use in arms, torso, lymphatic edema.

Top 5 Major Dominant Countries in the Upper Garments Application:

• United States: USD 365 million, 30% of Upper Garments globally; CAGR 8.7%.
• Germany: USD 145 million, 12%; CAGR 9.2%.
• Japan: USD 115 million, 10%; CAGR 9.1%.
• India: USD 110 million, 9%; CAGR 10.4%.
• UK: USD 85 million, 7%; CAGR 8.8%.

Lower Compression Garments: Lower compression garments (stockings, socks, calf, thigh) account for approx 50% of application share in broader product segmentation; in many reports lower garments dominate. Compression socks alone accounted for 35% of type share in 2023. Lower garments are used widely for varicose veins, deep vein thrombosis prevention, travel, post‑surgical lower limb recovery. The knee replacements and hip replacements figure (790,000 knee; 544,000 hip in U.S.) generate large demand for lower garment prosthetic and compression post‑operative care. Also high volume in outpatient and home healthcare settings: nursing care centers contribute 30% of usage for lower garment types in many region reports.

Lower Compression Garments are expected at about USD 1,822 million in 2025, roughly 60% share, with somewhat higher CAGR 9.4%, reflecting intense demand for stockings, socks, lower limb applications for varicose veins, DVT etc.

Top 5 Major Dominant Countries in the Lower Garments Application:• United States: USD 546 million, 30% of Lower Garments globally; CAGR 9.0%.• Germany: USD 220 million, 12%; CAGR 9.3%.• Japan: USD 175 million, 10%; CAGR 9.2%.• India: USD 150 million, 8%; CAGR 10.6%.• China: USD 140 million, 8%; CAGR 10.5%.

Medical Compression Garments Market Regional Outlook

Regional performance of Medical Compression Garments Market shows North America leading with about 38% share in 2025, Europe with 30–35%, Asia‑Pacific around 22‑25%, Latin America 5%, Middle East & Africa 4–5%. Regions differ by growth, adoption, regulatory environment, cost of healthcare, aging population, and disposable income. Distribution channels, reimbursement policies, and technology innovations vary widely across these regions.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America holds approximately 38% to 40% of Medical Compression Garments Market share by value in reports for 2024‑2025. The U.S. alone contributes about 37.5% of global compression therapy market value in 2023. Static compression therapy in North America accounts for roughly 66‑67% of the technology share in 2024. Hospitals and clinics in North America account for about 45% of the end‑user segment. Online retail in North America is contributing nearly 45% of purchases in some datasets, and offline retail about 55%. The aging population in U.S. of 58 million aged 65+ (17.3% of population) significantly drives demand. Vertical applications such as post‑surgical recovery (knee/hip replacements 1.334 million per year) add substantive unit volume for lower compression garments. U.S. reimbursement expansions for post‑operative compression garments in about 38% of employer‑sponsored health plans since 2021 also influence market growth.

In 2025 North America is expected to account for roughly USD 1,214 million, representing about 40% share of the global market, with CAGR around 8.8% over 2025‑2034, supported by strong healthcare infrastructure and reimbursement environment.

North America – Major Dominant Countries:

• United States: USD 1,050 million, dominating the region with 35%–40% share; CAGR 8.7%.
• Canada: USD 90 million, share 7%; CAGR 8.5%.
• Mexico: USD 40 million, share 3%; CAGR 9.5%.
• Brazil (if counted in NAFT‑adjacent trade flows / market spillover): USD 15 million, share 1%; CAGR 9.0%.
• Others in region: USD 19 million, remaining 2%; CAGR 9.0%.

EUROPE

Europe contributes about 30‑35% of global Medical Compression Garments Market share. In some reports, Europe holds the largest individual region share (35%) of total market value in 2024. Germany and the U.K. together account for about 20% of regional sales in Europe. Hospitals & clinics represent approximately 35% of European volume in compression garment usage; home care about 25%, nursing care centers 30% in some segmentation. Varicose vein treatment has very high incidence in Europe: up to 20‑30 million people in major European countries are affected, driving demand for lower compression garments (stockings, socks). Oncology indications are stronger in European markets with statutory health insurance covering over 23 surgical indications for compression garments in some countries. Material innovation (moisture‑wicking, breathable fabrics) is being adopted in Europe is projected to hold about USD 911 million in 2025, around 30% of global share, with a CAGR of about 8.9%, driven by aging populations, regulatory standards and increasing awareness.

Europe – Major Dominant Countries:

• Germany: USD 250 million, share 27% of Europe’s market; CAGR 9.2%.
• UK: USD 140 million, share 15%; CAGR 8.8%.
• France: USD 120 million, share 13%; CAGR 8.9%.
• Italy: USD 90 million, share 10%; CAGR 9.0%.
• Spain: USD 75 million, share 8%; CAGR 9.1%. over 40% of new European product lines.

ASIA-PACIFIC

Asia‑Pacific holds about 22‑25% of global Medical Compression Garments Market share as of 2023‑2024 data. It is the fastest‑growing region in many reports. China and India jointly drive roughly 30% of Asia‑Pacific’s demand. E‑commerce penetration in Asia‑Pacific for medical compression garments has increased by about 40% in recent years, especially in China, India, South Korea. Lower garment types are dominant in Asia‑Pacific, with compression socks and leg garments accounting for over 60% of product units. Oncology and post‑surgery types (including burn recovery) in Asia‑Pacific are growing at roughly 15‑20% annual unit growth. Hospitals & clinics end‑users represent about 40‑45% of usage; home care and outpatient care adding remainder. Pricing challenges exist: in some Asia‑Pacific markets raw material cost inflation has raised end‑user prices by 20% over past 2 years.

Asia (Asia‑Pacific excluding Middle East) is forecasted at about USD 687 million in 2025, roughly 22% share globally, with a higher CAGR around 10.2%, because of rising healthcare expenditure, growing awareness, and developing infrastructure.

Asia – Major Dominant Countries:

• China: USD 200 million, share 29% of Asia’s market; CAGR 10.5%.
• India: USD 150 million, share 22%; CAGR 10.8%.
• Japan: USD 130 million, share 19%; CAGR 9.5%.
• South Korea: USD 60 million, share 9%; CAGR 9.8%.
• Australia: USD 50 million, share 7%; CAGR 9.7%.

MIDDLE EAST & AFRICA

Middle East & Africa contribute around 4‑5% of global Medical Compression Garments Market share. Key markets include UAE, Saudi Arabia, South Africa. Awareness levels are lower; however, adoption for lymphedema and venous disorders has increased by 20‑25% in those regions. Hospitals & clinics dominate 70% of demand in MEA, while home care is smaller share (20‑25%), and online retail less than 10% in many countries though rising. Pricing and reimbursement remain major restraints: many MEA countries have less than 30% coverage for medical compression garments under public health schemes. Unit growth has been about 10‑15% annually in major MEA hubs.

The Middle East & Africa region is expected to contribute about USD 121 million in 2025, representing 4% share globally, with CAGR approximately 9.6%, as healthcare investments and access improve across GCC and parts of Africa.

Middle East & Africa – Major Dominant Countries:

• Saudi Arabia: USD 35 million, share 29% of MEA’s market; CAGR 10.0%.
• UAE: USD 25 million, share 20%; CAGR 9.8%.
• South Africa: USD 20 million, share 16%; CAGR 9.5%.
• Egypt: USD 15 million, share 12%; CAGR 9.7%.
• Nigeria: USD 10 million, share 8%; CAGR 9.9%.

List of Top Medical Compression Garments Market Companies

• Smith & Nephew PLC
• Medi GmbH & Co. Kg
• Cardinal Health, Inc.
• Bio Compression Systems, Inc.
• Sigvaris
• 3M Company
• Sanyleg SRL
• Medtronic PLC
• Paul Hartmann AG
• BSN Medical
• Julius Zorn GmbH (Juzo)
• Therafirm
• Medical Z
• Solaris Inc.
• Santemol Group Medikal
• Tynor Orthotics Pvt. Ltd.
• Jobst (A brand under Essity)
• Belsana Medical GmbH
• DJO Global, Inc.
• ArjoHuntleigh
• Gottfried Medical Inc.
• Bodyment
• Lipoelastic a.s.
• Marena Group, LLC
• Gibaud (Thuasne Group)
• Ames Walker
• ZTL
• Veinoplus
• NovaCare
• Medico International Inc.
• Varitex

Top Two Companies with Highest Market Shares

• Essity: Essity is among the top 2 manufacturers of medical compression garments globally; in between Essity and SIGVARIS they account for about 33% of global sales value in 2024. Essity holds a leading position in Compression Socks and Body Garments type segments, together with over 50% share of that combined type category.
• SIGVARIS: SIGVARIS is the other of the top 2; together with Essity commanding about 33% of global Medical Compression Garments Market value. SIGVARIS has strong presence in Europe and North America, particularly in varicose vein and oncology segments, holding leading share in medical grade compression garment lines.

Investment Analysis and Opportunities

Investment Analysis and Opportunities in the Medical Compression Garments Market are significant in multiple dimensions. First, investment in advanced fabrics (moisture‑wicking, antimicrobial, breathable, adaptive compression zones) offers opportunity: over 30% improvement in wearer comfort in trials when these fabrics are used, leading to lower abandonment and higher repeat purchases. Second, investment in digital measurement and fit technologies (3D scanning, custom fit) is being adopted by about 28‑30% of companies; this reduces misfit returns, which currently represent 30‑35% of online purchased units. Third, investments in distribution: e‑commerce now delivers over 45% of purchases in many developed markets, presenting opportunity to penetrate regions with low offline infrastructure. Fourth, expanding reimbursement coverage: in Germany over 23 surgical indications are now statutorily covered; in U.S., about 38% of employer‑sponsored health plans have added post‑operative compression garment coverage since 2021. Regions like Asia‑Pacific and MEA have many untapped markets where share currently 4‑5%, offering opportunity for early entrants. Also, investment in research in dynamic compression devices, wearable robotics, smart garments: peristaltic soft wearable robot devices exceeding 22 kPa pressure in test environments indicate high potential; technological integration could yield differentiated offerings. Finally, investment in manufacturing scale in lower cost centers could reduce material cost inflation (20% increase in raw material cost recently) to allow more affordable pricing.

New Product Development

Recent innovations in Medical Compression Garments Market in product development show several new offerings. Moisture‑wicking and breathable fabric technology has been adopted by roughly 40% of manufacturers releasing new lines in 2024‑2025. More than 28% of companies introduced adaptive compression garments or digitally measured fitting in last year. Dynamic compression devices using wearable robotic actuators have been developed that deliver pressures exceeding 22 kPa at 14 Hz frequency for massage or lymphatic flow enhancement. Post‑surgical girdles made with 3D‐knitted structures that improve compression gradients once thought achievable only by manual multi‑layer bandaging are now in about 20% of new premium product releases. Antimicrobial and odor control fabrics are included in over 30% of new premium garment SKUs. Face & neck compression garments with extra firm levels (>30 mmHg) designed for scar therapy post‐burn or reconstructive surgery now make up 5% of type mix but constitute a growing high margin niche. Also, custom size kits (multi‑pressure sleeves or alternating pressure garments) are being offered by about 25% of specialist companies.

Five Recent Developments

• In 2023, Medi GmbH & Co. introduced the Medi Rehab One compression stocking, available in both thigh and calf versions with open or closed toes, targeting post‑operative and ankle/Achilles injury care.
• In November 2024, Cardinal Health launched the Kendall SCD SmartFlow Compression System in U.S., offering advanced pneumatic compression for VTE prevention and circulation improvement.
• In September 2024, Tactile Systems Technology, Inc. reported clinical trial outcomes showing significant improvements in lymphedema patient outcomes using advanced pneumatic compression devices.
• Since 2023, more than 28% of companies globally introduced adaptive compression or digitally measured fitting lines.
• Between 2022‑2024, demand for custom‑fit compression garments increased by approx 20% globally, with particular growth seen in Asia‑Pacific and Latin America for post‑surgical and maternity segments.

Report Coverage of Medical Compression Garments Market

The Medical Compression Garments Market Report provides comprehensive coverage across product types, applications, technologies, distribution channels, and regions, representing 100% of the global market landscape. It analyzes type segmentation including compression socks (35%), body garments (25%), shorts & leggings (20%), post-surgical girdles (15%), and face & neck garments (5%). Application coverage includes lower garments (50–60%) and upper garments (35–40%). The report evaluates technology split between static compression (66–67%) and dynamic compression (33–34%), regional shares led by North America (38%), Europe (30–35%), Asia-Pacific (22–25%), and others (9–10%), providing detailed market sizing, trends, and competitive insights.

Medical Compression Garments Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 3317.47 Million in 2026
Market Size Value By	USD 7341.83 Million by 2035
Growth Rate	CAGR of 9.23% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Upper Compression Garments Lower Compression Garments By Application : Varicose Vein Wound Care Burns Oncology Other Indications
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample